| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 2 | 80 | 1,684 | 292 | - | - | - | 2,058 |
| - | - | - | - | 6 | 920 | 231 | - | - | - | 1,157 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 2,058 | 97.5% | -0.83 | 1,157 | 95.7% |
| Optic-unspecified(L) | 53 | 2.5% | -0.03 | 52 | 4.3% |
| upstream partner | # | NT | conns Cm33 | % In | CV |
|---|---|---|---|---|---|
| Dm2 (L) | 279 | ACh | 850 | 41.9% | 0.8 |
| Cm12 (L) | 29 | GABA | 256 | 12.6% | 1.1 |
| Mi15 (L) | 64 | ACh | 149 | 7.4% | 0.6 |
| Cm3 (L) | 49 | GABA | 140 | 6.9% | 0.6 |
| Tm5c (L) | 50 | Glu | 86 | 4.2% | 0.7 |
| MeVC8 (R) | 1 | ACh | 53 | 2.6% | 0.0 |
| MeTu1 (L) | 25 | ACh | 45 | 2.2% | 0.7 |
| MeVPMe6 (R) | 1 | Glu | 38 | 1.9% | 0.0 |
| MeVC20 (L) | 2 | Glu | 31 | 1.5% | 0.4 |
| LT58 (L) | 1 | Glu | 28 | 1.4% | 0.0 |
| Tm39 (L) | 18 | ACh | 25 | 1.2% | 0.5 |
| Cm9 (L) | 12 | Glu | 23 | 1.1% | 0.8 |
| MeVC7a (R) | 1 | ACh | 19 | 0.9% | 0.0 |
| Cm28 (L) | 6 | Glu | 19 | 0.9% | 0.4 |
| Cm5 (L) | 15 | GABA | 19 | 0.9% | 0.3 |
| MeVPMe5 (R) | 4 | Glu | 11 | 0.5% | 0.7 |
| Cm7 (L) | 4 | Glu | 11 | 0.5% | 0.5 |
| Dm8a (L) | 7 | Glu | 11 | 0.5% | 0.6 |
| Cm16 (L) | 5 | Glu | 10 | 0.5% | 0.5 |
| MeVP25 (L) | 1 | ACh | 9 | 0.4% | 0.0 |
| Cm14 (L) | 5 | GABA | 9 | 0.4% | 0.9 |
| Cm25 (L) | 3 | Glu | 9 | 0.4% | 0.5 |
| Cm8 (L) | 7 | GABA | 9 | 0.4% | 0.4 |
| MeVP2 (L) | 7 | ACh | 9 | 0.4% | 0.4 |
| Cm4 (L) | 5 | Glu | 8 | 0.4% | 0.5 |
| MeVP7 (L) | 4 | ACh | 8 | 0.4% | 0.4 |
| MeLo3a (L) | 5 | ACh | 8 | 0.4% | 0.3 |
| MeVC7b (R) | 1 | ACh | 7 | 0.3% | 0.0 |
| Cm21 (L) | 5 | GABA | 7 | 0.3% | 0.3 |
| Cm32 (L) | 1 | GABA | 6 | 0.3% | 0.0 |
| Cm20 (L) | 3 | GABA | 6 | 0.3% | 0.4 |
| Cm34 (L) | 1 | Glu | 5 | 0.2% | 0.0 |
| Dm8b (L) | 2 | Glu | 5 | 0.2% | 0.6 |
| Cm1 (L) | 4 | ACh | 5 | 0.2% | 0.3 |
| MeLo4 (L) | 5 | ACh | 5 | 0.2% | 0.0 |
| Cm24 (L) | 1 | Glu | 4 | 0.2% | 0.0 |
| aMe10 (R) | 1 | ACh | 4 | 0.2% | 0.0 |
| MeVP40 (L) | 1 | ACh | 4 | 0.2% | 0.0 |
| MeVP30 (L) | 1 | ACh | 4 | 0.2% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 4 | 0.2% | 0.0 |
| Cm23 (L) | 3 | Glu | 4 | 0.2% | 0.4 |
| Cm30 (L) | 2 | GABA | 4 | 0.2% | 0.0 |
| aMe30 (L) | 2 | Glu | 3 | 0.1% | 0.3 |
| Cm10 (L) | 3 | GABA | 3 | 0.1% | 0.0 |
| aMe_unclear (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| MeVC24 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| MeVC10 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| aMe17e (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| Cm15 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| Tm30 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| Cm6 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| Dm20 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| MeVP6 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| MeVP10 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Dm-DRA1 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| Cm11a (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| MeTu4a (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| MeVP8 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| MeTu4c (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| TmY10 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm19 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeLo5 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm40 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Mi10 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeTu4f (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm4 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeTu3b (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe9 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Lat3 (L) | 1 | unc | 1 | 0.0% | 0.0 |
| TmY17 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeTu3c (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm17 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| Cm-DRA (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP_unclear (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Cm11d (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| ME_unclear (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVPMe9 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP12 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe26 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm31b (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVC27 (R) | 1 | unc | 1 | 0.0% | 0.0 |
| MeVC25 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns Cm33 | % Out | CV |
|---|---|---|---|---|---|
| Cm6 (L) | 99 | GABA | 973 | 36.1% | 0.5 |
| MeTu1 (L) | 119 | ACh | 933 | 34.6% | 0.6 |
| Cm3 (L) | 74 | GABA | 168 | 6.2% | 0.5 |
| Cm5 (L) | 62 | GABA | 153 | 5.7% | 0.7 |
| Dm-DRA1 (L) | 15 | Glu | 58 | 2.2% | 0.4 |
| Dm2 (L) | 25 | ACh | 29 | 1.1% | 0.3 |
| TmY10 (L) | 13 | ACh | 28 | 1.0% | 0.6 |
| MeVP6 (L) | 15 | Glu | 28 | 1.0% | 0.6 |
| MeVP45 (L) | 1 | ACh | 25 | 0.9% | 0.0 |
| Cm-DRA (L) | 3 | ACh | 19 | 0.7% | 0.4 |
| aMe30 (L) | 2 | Glu | 15 | 0.6% | 0.2 |
| MeVC20 (L) | 2 | Glu | 13 | 0.5% | 0.7 |
| LOP_ME_unclear (L) | 1 | Glu | 12 | 0.4% | 0.0 |
| MeVP1 (L) | 8 | ACh | 12 | 0.4% | 0.3 |
| MeVPMe6 (L) | 1 | Glu | 11 | 0.4% | 0.0 |
| MeVPMe5 (L) | 4 | Glu | 11 | 0.4% | 0.5 |
| Cm12 (L) | 8 | GABA | 11 | 0.4% | 0.7 |
| Cm20 (L) | 6 | GABA | 10 | 0.4% | 0.3 |
| aMe25 (L) | 1 | Glu | 8 | 0.3% | 0.0 |
| Cm8 (L) | 6 | GABA | 7 | 0.3% | 0.3 |
| aMe_unclear (L) | 1 | Glu | 5 | 0.2% | 0.0 |
| MeVP27 (L) | 1 | ACh | 5 | 0.2% | 0.0 |
| aMe26 (L) | 1 | ACh | 5 | 0.2% | 0.0 |
| LT58 (L) | 1 | Glu | 5 | 0.2% | 0.0 |
| Cm9 (L) | 4 | Glu | 5 | 0.2% | 0.3 |
| aMe17e (L) | 1 | Glu | 4 | 0.1% | 0.0 |
| Cm23 (L) | 2 | Glu | 4 | 0.1% | 0.5 |
| MeVPMe10 (L) | 2 | Glu | 4 | 0.1% | 0.5 |
| aMe4 (L) | 3 | ACh | 4 | 0.1% | 0.4 |
| MeTu3c (L) | 3 | ACh | 4 | 0.1% | 0.4 |
| MeVP10 (L) | 3 | ACh | 4 | 0.1% | 0.4 |
| Cm11d (L) | 3 | ACh | 4 | 0.1% | 0.4 |
| MeLo3a (L) | 3 | ACh | 4 | 0.1% | 0.4 |
| Tm34 (L) | 1 | Glu | 3 | 0.1% | 0.0 |
| MeVP11 (L) | 1 | ACh | 3 | 0.1% | 0.0 |
| MeVP8 (L) | 1 | ACh | 3 | 0.1% | 0.0 |
| MeVP40 (L) | 1 | ACh | 3 | 0.1% | 0.0 |
| MeVP41 (L) | 1 | ACh | 3 | 0.1% | 0.0 |
| Cm16 (L) | 2 | Glu | 3 | 0.1% | 0.3 |
| MeLo6 (L) | 2 | ACh | 3 | 0.1% | 0.3 |
| Tm35 (L) | 2 | Glu | 3 | 0.1% | 0.3 |
| MeVP7 (L) | 2 | ACh | 3 | 0.1% | 0.3 |
| Cm30 (L) | 2 | GABA | 3 | 0.1% | 0.3 |
| Cm11a (L) | 3 | ACh | 3 | 0.1% | 0.0 |
| Cm28 (L) | 3 | Glu | 3 | 0.1% | 0.0 |
| MeTu4a (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeTu3b (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| Tm38 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| Tm1 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| Tm40 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| Cm24 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| MeVC24 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| MeVP55 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| Cm21 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| MeVC10 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP43 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| aMe20 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP49 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 2 | 0.1% | 0.0 |
| Cm1 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Cm7 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| ME_unclear (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| Cm14 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| Mi9 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| Cm10 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| MeVP2 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| aMe9 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| MeVP21 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Cm2 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm29 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Tm6 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Mi15 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm4 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeTu4d (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Lawf2 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm9 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| TmY9b (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm3 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm15 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeTu4c (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm5Y (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| C3 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| TmY9a (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeTu2a (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm27 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| TmY17 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm18 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Pm4 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeTu4f (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm31 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| aMe5 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm33 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeLo3b (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVPMe8 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP33 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm31b (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeVC9 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm31a (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeVPMe12 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVC25 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| aMe17a (L) | 1 | unc | 1 | 0.0% | 0.0 |